Back to
Bank of New York Mellon Corp
VIVO
Showing 0 of 15 quarters
Position history for
Bank of New York Mellon Corp's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Bank of New York Mellon held 409,347 shares of VIVO (Meridian Bioscience), worth $13.6M. Bank of New York Mellon's 13F filings listed VIVO from Q3 2019 to Q4 2022, 14 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.